Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine plus lidocaine for painless gastroenteroscopy in elderly patients
ChiCTR2400091789Phase 4Recruiting
- Sponsor
- Zhongshan People's Hospital
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine, lidocaine, ciprofol, sufentanil and propofol (2 arms), sponsored by Zhongshan People's Hospital. Primary endpoint: Postoperative visceral traction pain. Started Nov 2024; status: recruiting.
02
Drugs
esketaminelidocaineciprofolsufentanilpropofol
Beyond the preview
Go deeper on ChiCTR2400091789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091789.